Other studies indicate that DERL3 may exert an inhibitory effect in colorectal cancer, while the epigenetic loss of DERL3 induces the overexpression of SLC2A1, thereby influencing tumor progression through the Warburg effect [16,17]. Here, DERL3 is linked to colorectal cancer.